RxDoctor Payments Data

Joe Lee, MD

Orthopaedic Surgery of the Spine · Arcadia, CANPI 1437313095

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $325,875 of the $485,796 with a category attached, or 67.1%. 20 manufacturers reported payments, led by Spineart SA at 40.0% of the total. Reporting peaked in 2022 at $103,948 and has fallen 74.1% since, to $26,875 in 2025.

$485,796in general payments, 2019–2025

Across 169 payments — averaging $2874.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineart SA$194K
  • Choice Spine, LLC$175K
  • Spineart USA Inc$103K
  • Integrity Implants Inc.$7K
  • Kyocera Medical Technologies, Inc.$5K
  • Boston Scientific$451
  • plus $1K from 14 others

What the payments were for

  • Royalty or licence$325,87567%
  • Consulting fees$74,45715%
  • Travel & lodging$78,09416%
  • Food & beverage$7,3702%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$485,796 in reported general payments places this provider in the 85th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$536,926
Medicare patients
712
Services billed
3,448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin765$3,767
Diclofenac Sodium338$3,328
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen161$2,472
Celecoxib72$1,679
Lidocaine13$1,011
Calcitonin-SalmonCalcitonin,salmon,synthetic16$834
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$643
Methylprednisolone116$640
Cyclobenzaprine Hcl107$602
Pregabalin55$516
Tramadol Hcl113$262
Meloxicam110$170
Acetaminophen-CodeineAcetaminophen With Codeine13$154
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$66
Ibuprofen11$46

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Arcadia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →